Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710551 | 12571055 | 1 | I | 2005 | 20160628 | 20160719 | 20160719 | EXP | CA-GILEAD-2016-0221349 | GILEAD | 70.00 | YR | E | M | Y | 0.00000 | 20160719 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710551 | 12571055 | 1 | PS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 300 MG, EVERY 2 DAYS | U | 21356 | 300 | MG | TABLET | ||||||
| 125710551 | 12571055 | 2 | SS | EMTRIVA | EMTRICITABINE | 1 | Unknown | U | 0 | CAPSULE | |||||||||
| 125710551 | 12571055 | 3 | C | DARUNAVIR | DARUNAVIR | 1 | Unknown | 800 MG, QD | 0 | 800 | MG | QD | |||||||
| 125710551 | 12571055 | 4 | C | ABACAVIR. | ABACAVIR | 1 | Unknown | 300 MG, BID | 0 | 300 | MG | BID | |||||||
| 125710551 | 12571055 | 5 | C | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | 150 MG, BID | 0 | 150 | MG | BID | |||||||
| 125710551 | 12571055 | 6 | C | RITONAVIR. | RITONAVIR | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 125710551 | 12571055 | 7 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | 4 MG, QD | 0 | 4 | MG | QD | |||||||
| 125710551 | 12571055 | 8 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0.5 MG, PRN AT BEDTIME | 0 | .5 | MG | ||||||||
| 125710551 | 12571055 | 9 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 80 MG, QD | 0 | 80 | MG | QD | |||||||
| 125710551 | 12571055 | 10 | C | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | 2 MG, PRN | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125710551 | 12571055 | 1 | HIV infection |
| 125710551 | 12571055 | 2 | HIV infection |
| 125710551 | 12571055 | 3 | HIV infection |
| 125710551 | 12571055 | 4 | Product used for unknown indication |
| 125710551 | 12571055 | 5 | Product used for unknown indication |
| 125710551 | 12571055 | 6 | HIV infection |
| 125710551 | 12571055 | 7 | Product used for unknown indication |
| 125710551 | 12571055 | 8 | Product used for unknown indication |
| 125710551 | 12571055 | 9 | Product used for unknown indication |
| 125710551 | 12571055 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125710551 | 12571055 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125710551 | 12571055 | Drug ineffective | |
| 125710551 | 12571055 | Drug resistance | |
| 125710551 | 12571055 | Glomerular filtration rate decreased | |
| 125710551 | 12571055 | Nephropathy toxic | |
| 125710551 | 12571055 | Neurotoxicity | |
| 125710551 | 12571055 | Off label use | |
| 125710551 | 12571055 | Urine phosphorus increased | |
| 125710551 | 12571055 | Viral mutation identified |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |